Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 42 | 36 | −6 |
| Shares | 17.9M | 16.6M | −1.28M (−7.2%) |
| Value | $393.7M | $203.8M | −$189.9M (−48.2%) |
New holders (6)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 26,831 | $329.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 17,650 | $216.0K | 0.00% |
| Millennium Management LLC | 14,769 | $181.0K | 0.00% |
| Jane Street Group, LLC | 11,973 | $147.0K | 0.00% |
| Balyasny Asset Management LLC | 10,308 | $126.0K | 0.00% |
| Signaturefd, LLC | 60 | $1.00K | 0.00% |
Sold out (12)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Avidity Partners Management LP | 400,000 | $8.80M |
| PFM Health Sciences, LP | 329,274 | $7.24M |
| Sphera Funds Management Ltd. | 70,000 | $1.54M |
| Marshall Wace North America L.P. | 41,792 | $919.0K |
| Norges Bank | 23,068 | $507.0K |
| Zimmer Partners, LP | 22,500 | $495.0K |
| Pinz Capital Management, LP | 19,948 | $439.0K |
| Laurion Capital Management LP | 15,000 | $330.0K |
| Wells Fargo & Company | 2,714 | $60.0K |
| UBS Group AG | 2,546 | $56.0K |
| STRS Ohio | 2,100 | $46.0K |
| Bank of Montreal | 292 | $5.00K |